Compelling evidence that chronic neuroinflammation induces neurodegeneration in Parkinson’s disease (PD) Hypothesized that microglial inflammasome activation propagates chronic neuroinflammation in PD IC 100, a CNS-penetrating monoclonal ASC Inhibitor, targets multiple types of…
ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation with IC 100 Blocks Neuroinflammation Driving Parkinson’s Disease Pathology
